The Global Lysosomal Storage Diseases Market is expected to post a CAGR of 10.01 percent during the forecast period of 2013-2018.
London, 31 July 2014: TechNavio, an independent tech-focused global research firm, announced today the publication of its market research report on the Global Lysosomal Storage Diseases Market 2014-2018.
Lysosomal storage diseases refer to a group of diseases related to a deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.
The TechNavio report discussed the current treatments for the disease, which require lifelong administration and can associated with undesirable side effects, resulting in an increasing demand for drugs with better efficacy.
“The Global Lysosomal Storage Diseases Market is expected to grow because of legislative changes in developing countries promoting research for orphan diseases. Emerging economies are working on the development of regulatory protocols to curb these diseases,” says Faisal Ghaus, Vice President of TechNavio Research.
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3E%C2%A0%3C/p%3E%3Cp%3EIf%20you%20are%20in…
